English

VASOMEDICAL, INC

EDGAR

VASO Quarterly report (10-Q) · filed 2026-08-14

Annual consolidated revenue for 2025: about USD 89.1M, using the latest reported figures. The previous period, 2024, was about USD 86.77M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

19.4 million USD

2026 Q1 · USD

Exact inputs and evidence

Revenue: 19356000 USD Source

Operating margin

-6.87%

2026 Q1 · %

Exact inputs and evidence

Operating Income: -1330000 USD Source
Revenue: 19356000 USD Source

Operating cash flow

-12.6 million USD

2026 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -12625000 USD Source

Cash and cash equivalents: 38.3 million USD 2026-06-30 Source
Exact value

38291000 USD
Long-term debt including current maturities: 15 thousand USD 2022-12-31 Source
Exact value

15000 USD
Shares outstanding: 176 million shares 2026-06-30 Source
Exact value

176018035 shares

Reported share-count change

0.15% · 265 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

175753035 shares · 2025-06-30· Source
176018035 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-14.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2025-12-31
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 6 of 11 periods available· newest 2022-12-31
Total assets: 9 of 11 periods available· newest 2025-12-31
liabilities: No compatible figures in this window
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 5 of 11 periods available· newest 2022-12-31
Shares outstanding: 9 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+2.7%

Prior period

USD 86.77 million

2024-01-01 – 2024-12-31
Current period

USD 89.1 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

89096000 − 86767000 = 2329000 USD

86767000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
89096000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · VASOMEDICAL, INC · 2025-12-31 VASOMEDICAL, INC (edgar:839087) Year-over-year change in Revenue: 2329000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 89096000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm#888741 Filing: 000121390026037664 Input fundies:Revenue: 86767000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm#889405 Filing: 000121390026037664
The citation records this snapshot. The page link may show a newer release later.
Net income
+65%

Prior period

USD 951,000

2024-01-01 – 2024-12-31
Current period

USD 1.57 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

1569000 − 951000 = 618000 USD

951000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1569000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · VASOMEDICAL, INC · 2025-12-31 VASOMEDICAL, INC (edgar:839087) Year-over-year change in Net income: 618000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 1569000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm#525368 Filing: 000121390026037664 Input fundies:NetIncome: 951000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm#525714 Filing: 000121390026037664
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+182.6%

Prior period

USD 3.28 million

2024-01-01 – 2024-12-31
Current period

USD 9.27 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

9273000 − 3281000 = 5992000 USD

3281000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
9273000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · VASOMEDICAL, INC · 2025-12-31 VASOMEDICAL, INC (edgar:839087) Year-over-year change in Operating cash flow: 5992000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 9273000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm#543724 Filing: 000121390026037664 Input fundies:OperatingCashFlow: 3281000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm#544174 Filing: 000121390026037664
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 89.1 million 100% of revenue
Cost of revenue USD 34.42 million 39% of revenue
Operating expenses USD 57.56 million 65% of revenue
Operating income −USD 2.89 million −3.2% of revenue
Tax, interest and other Derived −USD 4.46 million −5% of revenue
Net income USD 1.57 million 1.8% of revenue

Cash

Operating cash flow USD 9.27 million 10% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 105% of revenue.
2018 Operating loss: operating costs were 105% of revenue.
2019 Net loss: net income was −0.5% of revenue.
2020 99%
2021 Net income was higher than operating income, so the split is not drawn.
2022 Net income was higher than operating income, so the split is not drawn.
2023 Net income was higher than operating income, so the split is not drawn.
2024 Net income was higher than operating income, so the split is not drawn.
2025 Operating loss: operating costs were 103% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	72788000	76620000 Derived	-3832000	707000 Derived	-4539000	-775000 Derived	Source 2017-01-01 – 2017-12-31: 72788000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -3832000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -4539000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 1599000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 2374000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	73980000	77704000 Derived	-3724000	10000 Derived	-3734000	-4039000 Derived	Source 2018-01-01 – 2018-12-31: 73980000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -3724000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -3734000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -1453000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 2586000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	75515000	74924000 Derived	591000	973000 Derived	-382000	-2538000 Derived	Source 2019-01-01 – 2019-12-31: 75515000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 591000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -382000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -1333000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 1205000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	69850000	69078000 Derived	772000	414000 Derived	358000	4934000 Derived	Source 2020-01-01 – 2020-12-31: 69850000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 772000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 358000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 5934000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 1000000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	75579000	72760000 Derived	2819000	-3281000 Derived	6100000	7400000 Derived	Source 2021-01-01 – 2021-12-31: 75579000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 2819000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 6100000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 7815000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 415000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	79294000	72840000 Derived	6454000	-4840000 Derived	11294000	13850000 Derived	Source 2022-01-01 – 2022-12-31: 79294000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 6454000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 11294000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 14416000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 566000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	81024000	76829000 Derived	4195000	-610000 Derived	4805000	Unavailable	Source 2023-01-01 – 2023-12-31: 81024000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: 4195000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: 4805000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 5296000 USD Inspect Operating Cash Flow Open source
2024 2024-01-01 – 2024-12-31	86767000	86482000 Derived	285000	-666000 Derived	951000	Unavailable	Source 2024-01-01 – 2024-12-31: 86767000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: 285000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 951000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 3281000 USD Inspect Operating Cash Flow Open source
2025 2025-01-01 – 2025-12-31	89096000	91987000 Derived	-2891000	-4460000 Derived	1569000	Unavailable	Source 2025-01-01 – 2025-12-31: 89096000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -2891000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: 1569000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 9273000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 89.1M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Revenue	72788000	Revenue: 72788000 Open source
20182018-12-31	Revenue	73980000	Revenue: 73980000 Open source
20192019-12-31	Revenue	75515000	Revenue: 75515000 Open source
20202020-12-31	Revenue	69850000	Revenue: 69850000 Open source
20212021-12-31	Revenue	75579000	Revenue: 75579000 Open source
20222022-12-31	Revenue	79294000	Revenue: 79294000 Open source
20232023-12-31	Revenue	81024000	Revenue: 81024000 Open source
20242024-12-31	Revenue	86767000	Revenue: 86767000 Open source
20252025-12-31	Revenue	89096000	Revenue: 89096000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

2.7% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 72788000 Open source
20182018-12-31	Year over year	1.6%	Revenue: 73980000 Open source Revenue: 72788000 Open source
20192019-12-31	Year over year	2.1%	Revenue: 75515000 Open source Revenue: 73980000 Open source
20202020-12-31	Year over year	-7.5%	Revenue: 69850000 Open source Revenue: 75515000 Open source
20212021-12-31	Year over year	8.2%	Revenue: 75579000 Open source Revenue: 69850000 Open source
20222022-12-31	Year over year	4.9%	Revenue: 79294000 Open source Revenue: 75579000 Open source
20232023-12-31	Year over year	2.2%	Revenue: 81024000 Open source Revenue: 79294000 Open source
20242024-12-31	Year over year	7.1%	Revenue: 86767000 Open source Revenue: 81024000 Open source
20252025-12-31	Year over year	2.7%	Revenue: 89096000 Open source Revenue: 86767000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -3.2% 2025

Net margin 1.8% 2025

Free cash flow margin 17.5% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	-5.3%	Operating Income: -3832000 Open source Revenue: 72788000 Open source
20182018-12-31	Operating margin	-5%	Operating Income: -3724000 Open source Revenue: 73980000 Open source
20192019-12-31	Operating margin	0.8%	Operating Income: 591000 Open source Revenue: 75515000 Open source
20202020-12-31	Operating margin	1.1%	Operating Income: 772000 Open source Revenue: 69850000 Open source
20212021-12-31	Operating margin	3.7%	Operating Income: 2819000 Open source Revenue: 75579000 Open source
20222022-12-31	Operating margin	8.1%	Operating Income: 6454000 Open source Revenue: 79294000 Open source
20232023-12-31	Operating margin	5.2%	Operating Income: 4195000 Open source Revenue: 81024000 Open source
20242024-12-31	Operating margin	0.3%	Operating Income: 285000 Open source Revenue: 86767000 Open source
20252025-12-31	Operating margin	-3.2%	Operating Income: -2891000 Open source Revenue: 89096000 Open source
20172017-12-31	Net margin	-6.2%	Net Income: -4539000 Open source Revenue: 72788000 Open source
20182018-12-31	Net margin	-5%	Net Income: -3734000 Open source Revenue: 73980000 Open source
20192019-12-31	Net margin	-0.5%	Net Income: -382000 Open source Revenue: 75515000 Open source
20202020-12-31	Net margin	0.5%	Net Income: 358000 Open source Revenue: 69850000 Open source
20212021-12-31	Net margin	8.1%	Net Income: 6100000 Open source Revenue: 75579000 Open source
20222022-12-31	Net margin	14.2%	Net Income: 11294000 Open source Revenue: 79294000 Open source
20232023-12-31	Net margin	5.9%	Net Income: 4805000 Open source Revenue: 81024000 Open source
20242024-12-31	Net margin	1.1%	Net Income: 951000 Open source Revenue: 86767000 Open source
20252025-12-31	Net margin	1.8%	Net Income: 1569000 Open source Revenue: 89096000 Open source
20172017-12-31	Free cash flow margin	-1.1%	Revenue: 72788000 Open source Operating Cash Flow: 1599000 Open source Capital Expenditure: 2374000 Open source
20182018-12-31	Free cash flow margin	-5.5%	Revenue: 73980000 Open source Operating Cash Flow: -1453000 Open source Capital Expenditure: 2586000 Open source
20192019-12-31	Free cash flow margin	-3.4%	Revenue: 75515000 Open source Operating Cash Flow: -1333000 Open source Capital Expenditure: 1205000 Open source
20202020-12-31	Free cash flow margin	7.1%	Revenue: 69850000 Open source Operating Cash Flow: 5934000 Open source Capital Expenditure: 1000000 Open source
20212021-12-31	Free cash flow margin	9.8%	Revenue: 75579000 Open source Operating Cash Flow: 7815000 Open source Capital Expenditure: 415000 Open source
20222022-12-31	Free cash flow margin	17.5%	Revenue: 79294000 Open source Operating Cash Flow: 14416000 Open source Capital Expenditure: 566000 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 81024000 Open source Operating Cash Flow: 5296000 Open source
20242024-12-31	Free cash flow margin	Not reported	Revenue: 86767000 Open source Operating Cash Flow: 3281000 Open source
20252025-12-31	Free cash flow margin	Not reported	Revenue: 89096000 Open source Operating Cash Flow: 9273000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 9.3M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Operating cash flow	1599000	Operating Cash Flow: 1599000 Open source
20182018-12-31	Operating cash flow	-1453000	Operating Cash Flow: -1453000 Open source
20192019-12-31	Operating cash flow	-1333000	Operating Cash Flow: -1333000 Open source
20202020-12-31	Operating cash flow	5934000	Operating Cash Flow: 5934000 Open source
20212021-12-31	Operating cash flow	7815000	Operating Cash Flow: 7815000 Open source
20222022-12-31	Operating cash flow	14416000	Operating Cash Flow: 14416000 Open source
20232023-12-31	Operating cash flow	5296000	Operating Cash Flow: 5296000 Open source
20242024-12-31	Operating cash flow	3281000	Operating Cash Flow: 3281000 Open source
20252025-12-31	Operating cash flow	9273000	Operating Cash Flow: 9273000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 13.9M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Free cash flow	-775000	Operating Cash Flow: 1599000 Open source Capital Expenditure: 2374000 Open source
20182018-12-31	Free cash flow	-4039000	Operating Cash Flow: -1453000 Open source Capital Expenditure: 2586000 Open source
20192019-12-31	Free cash flow	-2538000	Operating Cash Flow: -1333000 Open source Capital Expenditure: 1205000 Open source
20202020-12-31	Free cash flow	4934000	Operating Cash Flow: 5934000 Open source Capital Expenditure: 1000000 Open source
20212021-12-31	Free cash flow	7400000	Operating Cash Flow: 7815000 Open source Capital Expenditure: 415000 Open source
20222022-12-31	Free cash flow	13850000	Operating Cash Flow: 14416000 Open source Capital Expenditure: 566000 Open source
20232023-12-31	Free cash flow	Unavailable	Operating Cash Flow: 5296000 Open source
20242024-12-31	Free cash flow	Unavailable	Operating Cash Flow: 3281000 Open source
20252025-12-31	Free cash flow	Unavailable	Operating Cash Flow: 9273000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2017-12-31	Liabilities / assets	Not reported	Total Assets: 56778000 Open source
2018-12-31	Liabilities / assets	Not reported	Total Assets: 50474000 Open source
2019-12-31	Liabilities / assets	Not reported	Total Assets: 54364000 Open source
2020-12-31	Liabilities / assets	Not reported	Total Assets: 50376000 Open source
2021-12-31	Liabilities / assets	Not reported	Total Assets: 52361000 Open source
2022-12-31	Liabilities / assets	Not reported	Total Assets: 71645000 Open source
2023-12-31	Liabilities / assets	Not reported	Total Assets: 75757000 Open source
2024-12-31	Liabilities / assets	Not reported	Total Assets: 82938000 Open source
2025-12-31	Liabilities / assets	Not reported	Total Assets: 88349000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.59× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Current assets / current liabilities	0.76×	Current Assets: 25487000 Open source Current Liabilities: 33704000 Open source
20182018-12-31	Current assets / current liabilities	0.54×	Current Assets: 19174000 Open source Current Liabilities: 35353000 Open source
20192019-12-31	Current assets / current liabilities	0.73×	Current Assets: 24059000 Open source Current Liabilities: 33003000 Open source
20202020-12-31	Current assets / current liabilities	0.7×	Current Assets: 22268000 Open source Current Liabilities: 31699000 Open source
20212021-12-31	Current assets / current liabilities	0.9×	Current Assets: 27803000 Open source Current Liabilities: 31000000 Open source
20222022-12-31	Current assets / current liabilities	1.3×	Current Assets: 40990000 Open source Current Liabilities: 31506000 Open source
20232023-12-31	Current assets / current liabilities	1.5×	Current Assets: 45099000 Open source Current Liabilities: 30040000 Open source
20242024-12-31	Current assets / current liabilities	1.47×	Current Assets: 51185000 Open source Current Liabilities: 34720000 Open source
20252025-12-31	Current assets / current liabilities	1.59×	Current Assets: 58560000 Open source Current Liabilities: 36846000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	−USD 4.54 million Exact value Exact value: -4539000 USD 2017-01-01 – 2017-12-31: -4539000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VASOMEDICAL, INC · 2017-12-31 VASOMEDICAL, INC (edgar:839087) Net Income: -4539000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4539000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495419004395/vaso-20181231.xml#158538 Filing: 000165495419004395 The citation records this snapshot. The page link may show a newer release later.	USD 1.6 million Exact value Exact value: 1599000 USD 2017-01-01 – 2017-12-31: 1599000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VASOMEDICAL, INC · 2017-12-31 VASOMEDICAL, INC (edgar:839087) Operating Cash Flow: 1599000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1599000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495419004395/vaso-20181231.xml#164924 Filing: 000165495419004395 The citation records this snapshot. The page link may show a newer release later.	USD 2.37 million Exact value Exact value: 2374000 USD 2017-01-01 – 2017-12-31: 2374000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VASOMEDICAL, INC · 2017-12-31 VASOMEDICAL, INC (edgar:839087) Capital Expenditure: 2374000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2374000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495419004395/vaso-20181231.xml#170443 Filing: 000165495419004395 The citation records this snapshot. The page link may show a newer release later.	−USD 775,000 Calculation and evidence 1599000 − 2374000 USD Exact free cash flow: -775000 USD 2017-01-01 – 2017-12-31: 1599000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 2374000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VASOMEDICAL, INC · 2017-12-31 VASOMEDICAL, INC (edgar:839087) Free cash flow: -775000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1599000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495419004395/vaso-20181231.xml#164924 Filing: 000165495419004395 Input fundies:CapitalExpenditure: 2374000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495419004395/vaso-20181231.xml#170443 Filing: 000165495419004395 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 3.73 million Exact value Exact value: -3734000 USD 2018-01-01 – 2018-12-31: -3734000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VASOMEDICAL, INC · 2018-12-31 VASOMEDICAL, INC (edgar:839087) Net Income: -3734000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3734000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495420004060/vaso-20191231.xml#155096 Filing: 000165495420004060 The citation records this snapshot. The page link may show a newer release later.	−USD 1.45 million Exact value Exact value: -1453000 USD 2018-01-01 – 2018-12-31: -1453000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VASOMEDICAL, INC · 2018-12-31 VASOMEDICAL, INC (edgar:839087) Operating Cash Flow: -1453000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1453000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495420004060/vaso-20191231.xml#165388 Filing: 000165495420004060 The citation records this snapshot. The page link may show a newer release later.	USD 2.59 million Exact value Exact value: 2586000 USD 2018-01-01 – 2018-12-31: 2586000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VASOMEDICAL, INC · 2018-12-31 VASOMEDICAL, INC (edgar:839087) Capital Expenditure: 2586000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2586000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495420004060/vaso-20191231.xml#165745 Filing: 000165495420004060 The citation records this snapshot. The page link may show a newer release later.	−USD 4.04 million Calculation and evidence -1453000 − 2586000 USD Exact free cash flow: -4039000 USD 2018-01-01 – 2018-12-31: -1453000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 2586000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VASOMEDICAL, INC · 2018-12-31 VASOMEDICAL, INC (edgar:839087) Free cash flow: -4039000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1453000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495420004060/vaso-20191231.xml#165388 Filing: 000165495420004060 Input fundies:CapitalExpenditure: 2586000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495420004060/vaso-20191231.xml#165745 Filing: 000165495420004060 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 382,000 Exact value Exact value: -382000 USD 2019-01-01 – 2019-12-31: -382000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VASOMEDICAL, INC · 2019-12-31 VASOMEDICAL, INC (edgar:839087) Net Income: -382000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -382000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495421005117/vaso-20201231.xml#156382 Filing: 000165495421005117 The citation records this snapshot. The page link may show a newer release later.	−USD 1.33 million Exact value Exact value: -1333000 USD 2019-01-01 – 2019-12-31: -1333000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VASOMEDICAL, INC · 2019-12-31 VASOMEDICAL, INC (edgar:839087) Operating Cash Flow: -1333000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1333000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495421005117/vaso-20201231.xml#171384 Filing: 000165495421005117 The citation records this snapshot. The page link may show a newer release later.	USD 1.21 million Exact value Exact value: 1205000 USD 2019-01-01 – 2019-12-31: 1205000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VASOMEDICAL, INC · 2019-12-31 VASOMEDICAL, INC (edgar:839087) Capital Expenditure: 1205000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1205000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495421005117/vaso-20201231.xml#171741 Filing: 000165495421005117 The citation records this snapshot. The page link may show a newer release later.	−USD 2.54 million Calculation and evidence -1333000 − 1205000 USD Exact free cash flow: -2538000 USD 2019-01-01 – 2019-12-31: -1333000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1205000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VASOMEDICAL, INC · 2019-12-31 VASOMEDICAL, INC (edgar:839087) Free cash flow: -2538000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1333000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495421005117/vaso-20201231.xml#171384 Filing: 000165495421005117 Input fundies:CapitalExpenditure: 1205000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495421005117/vaso-20201231.xml#171741 Filing: 000165495421005117 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 358,000 Exact value Exact value: 358000 USD 2020-01-01 – 2020-12-31: 358000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VASOMEDICAL, INC · 2020-12-31 VASOMEDICAL, INC (edgar:839087) Net Income: 358000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 358000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495422004333/vaso_10k.htm#791234 Filing: 000165495422004333 The citation records this snapshot. The page link may show a newer release later.	USD 5.93 million Exact value Exact value: 5934000 USD 2020-01-01 – 2020-12-31: 5934000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VASOMEDICAL, INC · 2020-12-31 VASOMEDICAL, INC (edgar:839087) Operating Cash Flow: 5934000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5934000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495422004333/vaso_10k.htm#828149 Filing: 000165495422004333 The citation records this snapshot. The page link may show a newer release later.	USD 1 million Exact value Exact value: 1000000 USD 2020-01-01 – 2020-12-31: 1000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VASOMEDICAL, INC · 2020-12-31 VASOMEDICAL, INC (edgar:839087) Capital Expenditure: 1000000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1000000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495422004333/vaso_10k.htm#1136360 Filing: 000165495422004333 The citation records this snapshot. The page link may show a newer release later.	USD 4.93 million Calculation and evidence 5934000 − 1000000 USD Exact free cash flow: 4934000 USD 2020-01-01 – 2020-12-31: 5934000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VASOMEDICAL, INC · 2020-12-31 VASOMEDICAL, INC (edgar:839087) Free cash flow: 4934000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5934000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495422004333/vaso_10k.htm#828149 Filing: 000165495422004333 Input fundies:CapitalExpenditure: 1000000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495422004333/vaso_10k.htm#1136360 Filing: 000165495422004333 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 6.1 million Exact value Exact value: 6100000 USD 2021-01-01 – 2021-12-31: 6100000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VASOMEDICAL, INC · 2021-12-31 VASOMEDICAL, INC (edgar:839087) Net Income: 6100000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 6100000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495423004142/vaso_10k.htm#754636 Filing: 000165495423004142 The citation records this snapshot. The page link may show a newer release later.	USD 7.82 million Exact value Exact value: 7815000 USD 2021-01-01 – 2021-12-31: 7815000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VASOMEDICAL, INC · 2021-12-31 VASOMEDICAL, INC (edgar:839087) Operating Cash Flow: 7815000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7815000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495423004142/vaso_10k.htm#832871 Filing: 000165495423004142 The citation records this snapshot. The page link may show a newer release later.	USD 415,000 Exact value Exact value: 415000 USD 2021-01-01 – 2021-12-31: 415000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VASOMEDICAL, INC · 2021-12-31 VASOMEDICAL, INC (edgar:839087) Capital Expenditure: 415000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 415000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495423004142/vaso_10k.htm#1164534 Filing: 000165495423004142 The citation records this snapshot. The page link may show a newer release later.	USD 7.4 million Calculation and evidence 7815000 − 415000 USD Exact free cash flow: 7400000 USD 2021-01-01 – 2021-12-31: 7815000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 415000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VASOMEDICAL, INC · 2021-12-31 VASOMEDICAL, INC (edgar:839087) Free cash flow: 7400000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7815000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495423004142/vaso_10k.htm#832871 Filing: 000165495423004142 Input fundies:CapitalExpenditure: 415000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495423004142/vaso_10k.htm#1164534 Filing: 000165495423004142 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 11.29 million Exact value Exact value: 11294000 USD 2022-01-01 – 2022-12-31: 11294000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VASOMEDICAL, INC · 2022-12-31 VASOMEDICAL, INC (edgar:839087) Net Income: 11294000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 11294000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390024028734/ea0202244-10k_vasocorp.htm#663993 Filing: 000121390024028734 The citation records this snapshot. The page link may show a newer release later.	USD 14.42 million Exact value Exact value: 14416000 USD 2022-01-01 – 2022-12-31: 14416000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VASOMEDICAL, INC · 2022-12-31 VASOMEDICAL, INC (edgar:839087) Operating Cash Flow: 14416000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 14416000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390024028734/ea0202244-10k_vasocorp.htm#696370 Filing: 000121390024028734 The citation records this snapshot. The page link may show a newer release later.	USD 566,000 Exact value Exact value: 566000 USD 2022-01-01 – 2022-12-31: 566000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VASOMEDICAL, INC · 2022-12-31 VASOMEDICAL, INC (edgar:839087) Capital Expenditure: 566000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 566000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495423004142/vaso_10k.htm#1163852 Filing: 000165495423004142 The citation records this snapshot. The page link may show a newer release later.	USD 13.85 million Calculation and evidence 14416000 − 566000 USD Exact free cash flow: 13850000 USD 2022-01-01 – 2022-12-31: 14416000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 566000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VASOMEDICAL, INC · 2022-12-31 VASOMEDICAL, INC (edgar:839087) Free cash flow: 13850000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 14416000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390024028734/ea0202244-10k_vasocorp.htm#696370 Filing: 000121390024028734 Input fundies:CapitalExpenditure: 566000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000165495423004142/vaso_10k.htm#1163852 Filing: 000165495423004142 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	USD 4.81 million Exact value Exact value: 4805000 USD 2023-01-01 – 2023-12-31: 4805000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VASOMEDICAL, INC · 2023-12-31 VASOMEDICAL, INC (edgar:839087) Net Income: 4805000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: 4805000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390025026337/ea0234345-10k_vasocorp.htm#542275 Filing: 000121390025026337 The citation records this snapshot. The page link may show a newer release later.	USD 5.3 million Exact value Exact value: 5296000 USD 2023-01-01 – 2023-12-31: 5296000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VASOMEDICAL, INC · 2023-12-31 VASOMEDICAL, INC (edgar:839087) Operating Cash Flow: 5296000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5296000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390025026337/ea0234345-10k_vasocorp.htm#559888 Filing: 000121390025026337 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2024-01-01 – 2024-12-31	USD 951,000 Exact value Exact value: 951000 USD 2024-01-01 – 2024-12-31: 951000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VASOMEDICAL, INC · 2024-12-31 VASOMEDICAL, INC (edgar:839087) Net Income: 951000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: 951000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm#525714 Filing: 000121390026037664 The citation records this snapshot. The page link may show a newer release later.	USD 3.28 million Exact value Exact value: 3281000 USD 2024-01-01 – 2024-12-31: 3281000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VASOMEDICAL, INC · 2024-12-31 VASOMEDICAL, INC (edgar:839087) Operating Cash Flow: 3281000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3281000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm#544174 Filing: 000121390026037664 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2025-01-01 – 2025-12-31	USD 1.57 million Exact value Exact value: 1569000 USD 2025-01-01 – 2025-12-31: 1569000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VASOMEDICAL, INC · 2025-12-31 VASOMEDICAL, INC (edgar:839087) Net Income: 1569000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1569000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm#525368 Filing: 000121390026037664 The citation records this snapshot. The page link may show a newer release later.	USD 9.27 million Exact value Exact value: 9273000 USD 2025-01-01 – 2025-12-31: 9273000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VASOMEDICAL, INC · 2025-12-31 VASOMEDICAL, INC (edgar:839087) Operating Cash Flow: 9273000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T22:20:58Z Snapshot: c35bc255daecf82fc753a211da7fb961ff9be80ba244b745d783fda5ea8be80b Dimensions: Consolidated View: https://fundies.io/companies/edgar/839087/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 9273000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm#543724 Filing: 000121390026037664 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

140 filings · 12,834 latest values · 12,838 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000839087, 839087, VASO, edgar:839087

Also known as VASO CORPORATION, VASO Corp, VASOMEDICAL INC, VASOMEDICAL, INC

VASOMEDICAL, INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation